- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01657994
Combined Functional Electrical Stimulation & Robotic Gait Training for Children With Cerebral Palsy
August 31, 2016 updated by: Children's Hospital Medical Center, Cincinnati
The purpose of this research study is to learn more about the usefulness of a physical therapy treatment that combines robot-assisted walking with electrical impulses that help to make muscles contract.
This treatment is intended for children with cerebral palsy.
Up to eleven children with cerebral palsy will receive up to 18 treatments and will have several evaluations before and after treatment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
6
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- Cincinnati Children's Hospital Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 12 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- GMFCS II, III, or IV cerebral palsy
- 5-12 years of age
- meet safety criteria for robotic gait training (<300 lbs, intact skin, femoral length 21-47 cm, ability to follow simple instructions)
- meet safety criteria for functional electrical stimulation (voluntary hip and knee muscle contraction, intact skin)
Exclusion Criteria:
- planned major intervention during study period
- contractures that interfere with upright stance
- history of non-traumatic long bone fracture or clinically significant osteoporosis
- significant concurrent illness
- significant condition not typically associated with cerebral palsy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: therapy plus fes
robotic gait training plus functional electrical stimulation
|
up to 18 sessions of approximately 45 minutes occurring over up to 9 weeks
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Gross Motor Function Measure-66 using multiple baseline assessments
Time Frame: 4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in strength via myometry
Time Frame: 4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
|
Change in Observational Gait Scale
Time Frame: 4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
|
Change in Modified Ashworth Scale
Time Frame: 4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
|
Change in Goniometry at the knee
Time Frame: 4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
|
Change in 6 minute walk
Time Frame: 4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
|
Change in 10 meter walk
Time Frame: 4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
|
Change in Children's Assessment of Participation and Enjoyment
Time Frame: 4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
|
Change in Cerebral Palsy Quality of Life Questionnaire
Time Frame: 4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
|
Change in Canadian Occupational Performance Measure
Time Frame: 4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
4 times (9-0 weeks) before treatment, 3 times (6-12 weeks) after treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Jilda Vargus-Adams, MD MSc, Children's Hospital Medical Center, Cincinnati
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2012
Primary Completion (ACTUAL)
July 1, 2013
Study Completion (ACTUAL)
September 1, 2013
Study Registration Dates
First Submitted
May 17, 2012
First Submitted That Met QC Criteria
August 1, 2012
First Posted (ESTIMATE)
August 6, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
September 1, 2016
Last Update Submitted That Met QC Criteria
August 31, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R-796-10
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.